Journals / Türk Oftalmoloji Dergisi / 2014 / Cilt: 44 - Sayı: 5

Bilateral acute angle-closure glaucoma ınduced by escitalopram

Essitalopram kullanımına bağlı gelişen bilateral açı kapanması glokomu

Pages
396–399
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the following year, she did not begin escitalopram medication again and no other acute angle-closure attack was seen. (Turk J Ophthalmol 2014; 44:396-9)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Escitalopram is an antidepressant of the selective serotonin reuptake inhibitor(SSRI) class.
📊
Key Findings & Data:A 46-year-old female patient was admitted to our ophthalmology clinic with complaints of severe pain around the both eyes, headache, nausea, and vomiting for two days.
💡
Conclusion & Impact:In the following year, she did not begin escitalopram medication again and no other acute angle-closure attack was seen. (Turk J Ophthalmol 2014; 44:396-9)
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Escitalopram is an antidepressant of the selective serotonin reuptake inhibitor(SSRI) class. In this manuscript, we report the case of a female patient who developed bilateral acute angle-closure glaucoma induced by escitalopram. A 46-year-old female patient was admitted to our ophthalmology clinic with complaints of severe pain around the both eyes, headache, nausea, and vomiting for two days. In her past medical history, she was using escitalopram for depression for two years. Visual acuity was at hand movement level in both eyes. Anterior segment examination showed bilateral diffuse conjunctival hyperemia, corneal edema, shallow anterior chamber, and fixed dilated pupils. Intraocular pressure was 47 mmHg in the right and 68 mmHg in the left eye. The diagnosis was acute angle-closure glaucoma, and the escitalopram medication was discontinued. She was treated with topical and systemic antiglaucomatous medication. After the cornea become clear, bilateral peripheral laser iridotomy was done. In the following year, she did not begin escitalopram medication again and no other acute angle-closure attack was seen. (Turk J Ophthalmol 2014; 44:396-9)

Özet

Depresyon tedavisi için selektif serotonin geri alım inhibitörü (SSRI) sınıfından bir ilaç olan essitalopram kullanımına bağlı gelişen bilateral akut açı kapanması glokomu (AAKG) olgusu bildirilmektedir. Kırk altı yaşındaki bayan hasta her iki gözünde ve başında ağrı, görme azlığı, bulantı ve kusma şikayetleri ile göz hastalıkları polikliniğine başvurdu. Anamnezinde depresyon tedavisi amacı ile 2 yıldır essitalopram kullanımı dışında bir özellik yoktu. Nörolojik muayenesi normal bulundu. Oftalmolojik muayenesinde bilateral korneal ödem, sığ ön kamara, pupillalar dilate ve pupilla ışık reaksiyonları cevapsız olarak saptandı. Göz içi basınçları sağda 47 mmHg, solda 68 mmHg ölçüldü. Hastaya ilaca bağlı bilateral AAKG tanısı konularak kullandığı essitalopram tedavisi kesildi. Hastaya topikal ve sistemik antiglokomatöz tedavi başlandı ve kornea ödemi gerilemesi ile bilateral periferik laser iridotomi uygulandı. Hastanın bir yıllık takibi boyunca essitalopram tedavisi başlanmadı ve yeni bir açı kapanması glokomu atağı gelişmedi. (Turk J Ophthalmol 2014; 44:396-9)

🔖

Cite This Article

YILDIZ, D. E., CEBECİ, Z., BAYRAKTAR, Ş., İZGİ, B. (2022). Bilateral acute angle-closure glaucoma ınduced by escitalopram. Türk Oftalmoloji Dergisi, Cilt: 44 - Sayı: 5, 396–399. https://ajindex.com/articles/638064

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Salmon JF. Predisposing factors for chronic angle-closure glaucoma. Prog Retin Eye Res. 1999;18:121-32.
  2. Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007;18:129-33.
  3. Ikeda N, Ikeda T, Nagata M, Mimura O. Ciliochoroidal effusion syndrome induced by sulfa derivatives. Arch Ophthalmol. 2002;120:1775. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British AssociationPsychopharmacology. J Psychopharmacol. 2000;14:3-20. Ahmad S. Fluoxetine and glaucoma. DICP. 1991;25:436. Eke T, Bates AK. Acute angle closure glaucoma associated with paroxetine. BMJ. 1997;314:1387. Ezra DG, Storoni M, Whitefield LA. Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment. Eye (Lond). 2006;20:128-9. Jiménez-Jiménez FJ, Ortí-Pareja M, Zurdo JM. Aggravation of glaucoma with fluvoxamine. Ann Pharmacother. 2001;35:1565-6.
  4. Croos R, Thirumalai S, Hassan S, Davis Jda R. Citalopram associated with acute angle-closure glaucoma: case report. BMC Ophthalmol. 2005;5:23. Zelefsky JR, Fine HF, Rubinstein VJ, Hsu IS, Finger PT. Escitalopram-induced uveal effusions and bilateral angle closure glaucoma. Am J Ophthalmol. 2006;141:1144-7. European Glaucoma Society. Primitive angle closure. In: Guide for glaucoma 2nd edition. Dogma, Savona, Ital; 2003. p. 2-13.
  5. Osborne NN, Tobin AB. Serotonin accumulating cells in the iris-ciliary body and cornea of various species. Exp Eye Res. 1987;44:731-45.
  6. Costagliola C, Parmeggiani F, Semeraro F, Sebastiani A. Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure. Curr Neuropharmacol. 2008;6:293-310.